Life Sciences and Health Care
The healthcare sector has strong long-term drivers: the aging population demographic is leading to increased demand for healthcare products and services; growing patient awareness is leading to increased expectation of better treatment and services; and technological advances are leading to new types of treatment. Although the availability of government funding is a crucial factor for the healthcare sector, these long-term trends should remain in place. There is also an increasing need for private equity to deliver more capacity and quality of care into the system.
Major trends are shaping the life sciences and health care industry today:
-
Globalization is underway as pharmaceutical companies look to emerging markets for low-cost R and D and manufacturing support. China and India are playing increasingly larger roles in this process as the trend in outsourcing continues to strengthen.
-
The decline of employee-sponsored health care is accelerating consolidation among U.S. payers and providers.
-
The rise of personalized medicine is having profound effects on companies’ strategies across the industry.
-
IT improvements are driving unprecedented economies of scale for those companies that can afford it, thereby giving larger companies a competitive advantage.
We partner with businesses that develop and market innovative products to address unmet medical needs and/or help reduce cost. We remain focused on assisting businesses that own or are developing IP-protected products, and primarily target later-stage opportunities with reduced technical risk and a clear route to revenues and profitability. To help entrepreneurs raise capital, we believe companies benefit from products in clinical trials, strategic partnerships, low-capital requirements; short development times while still targeting the unmet needs in high-growth markets.
Four clear business models of interest to ILEX are: asset/facilities-based businesses, businesses based on distribution networks that can be leveraged; companies with innovative technology that are able to deliver treatments or services in a different and more effective way; and companies built around good, long-term contracts within the health system. In short, a wide range of opportunities, from drug discovery and medical technology to acute and long term care services will continue to drive the overall health care sector. ILEX helps companies to maximize the potential of their market leading products and services by identifying viable alternative funding options. Sectors include:
- Biotechnology
- Medical Devices and Equipment
- Beauty and Personal Care
- Pharmaceuticals
- Healthcare IT
- Health Care Services
- Medical Information
Systems